Search BSPK
Bespoke Extracts, Inc.
OTC · CIK 1409197
Last close0
Daily change+0.00 (0.00%)
10 Years gain-99.99%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
BSPK · STANDARD
SIC 2834 · Pharmaceutical Preparations · Fiscal year end 1231
Fundamental
40.5Momentum
100.0Acceleration
100.0Confidence
72.0Annual Revenue6
Quarterly Revenue17
Annual CFO13
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth25.0 / 25
Quality3.8 / 25
Capital Efficiency0.0 / 20
Balance Sheet8.6 / 15
Shareholder Economics1.1 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 2.0447 percentage points.
Operating leverageOperating margin improved by 54.7142 percentage points.
Warnings
Receivables anomaly · MEDIUMAccounts receivable growth is materially above revenue growth.
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Heavy share dilution · HIGHDiluted share count increased 10.6384%.
Possible growth trap · HIGHRevenue growth is high, but quality indicators are deteriorating.
Key Metrics
Revenue Growth TTM33.66%OK
Revenue CAGR 3Y215.55%OK
Gross Margin46.99%OK
Operating Margin-51.72%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFO0.11xOK
Diluted Share Growth 1Y10.64%OK
SBC / Revenue9.48%OK
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 FY Dec 31, 2024 | $1.12M | $452,935.00 | -$994,628.00 | -$289,802.00 | -$889,802.00 | 40.53% | -89.01% | -79.63% | n/a | 10.53M |
| 2024 FY Dec 31, 2023 | $785,453.00 | $343,164.00 | -$1.47M | -$415,198.00 | n/a | 43.69% | -187.41% | n/a | n/a | 10.17M |
| 2023 FY Dec 31, 2022 | $3,407.00 | $2,258.00 | -$4.02M | -$798,067.00 | -$805,269.00 | 66.28% | -118,011.59% | -23,635.72% | n/a | 9.37M |
| 2022 FY Aug 31, 2021 | $35,566.00 | $21,997.00 | -$965,577.00 | -$1.04M | -$1.04M | 61.85% | -2,714.89% | -2,934.57% | n/a | 5.16M |
| 2021 FY Aug 31, 2020 | n/a | $4,549.00 | -$4.02M | -$465,240.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1.40M | sum latest 4 fiscal quarters Revenue | OK | 0001213900-25-108632, 0001213900-25-059645 |
| Revenue Growth TTM | 33.66% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001213900-25-108632, 0001213900-25-059645 |
| Revenue CAGR 3Y | 215.55% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001213900-25-033608 |
| Revenue CAGR 5Y | 134.03% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001213900-25-033608 |
| Gross Profit CAGR 3Y | 174.09% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001213900-25-033608 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001213900-25-108632, 0001213900-25-059645 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 46.99% | Gross Profit / Revenue | OK | 0001213900-25-108632, 0001213900-25-059645 |
| Operating Margin | -51.72% | Operating Income / Revenue | OK | 0001213900-25-108632, 0001213900-25-059645 |
| Net Debt / CFO | 0.11x | Net Debt / CFO | OK | 0001213900-25-108632, 0001213900-25-081047 |
| Current Ratio | 0.11x | Current Assets / Current Liabilities | OK | derived |
| SBC / Revenue | 9.48% | SBC / Revenue | OK | 0001213900-25-108632, 0001213900-25-081047 |
| Revenue per Diluted Share | $0.12 | Revenue / Diluted Shares | OK | 0001213900-25-108632, 0001213900-25-059645 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | 0001213900-25-108632, 0001213900-25-081047 |